Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Hulot, Jean Sébastien ^a,b   Stillitano, Francesca ^a   Salem, Joe Elie ^b   Kovacic, Jason C ^a   Fuster, Valentin ^a   Hajjar, Roger J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL POPULATION; CELL RENEWAL; CELL SURVIVAL; CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENGRAFTMENT; GOOD MANUFACTURING PRACTICE; GRAFT REJECTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOGENICITY; NONHUMAN; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL DERIVED CARDIOMYOCYTE TRANSPLANTATION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SPINAL CORD INJURY; STARGARDT DISEASE; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; HEART MUSCLE CELL; PROCEDURES; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84892631897     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt390     Document Type: Review

References (63)

1. Cardiac stem cell therapy and the promise of heart regeneration. JC Garbern, RT Lee, Cell Stem Cell 2013 12 689 698 10.1016/j.stem.2013.05.008 23746978
2. Transient regenerative potential of the neonatal mouse heart. ER Porrello, AI Mahmoud, E Simpson, JA Hill, JA Richardson, EN Olson, HA Sadek, Science 2011 331 1078 1080 10.1126/science.1200708 21350179
3. Evidence for cardiomyocyte renewal in humans. O Bergmann, RD Bhardwaj, S Bernard, S Zdunek, F Barnabe-Heider, S Walsh, J Zupicich, K Alkass, BA Buchholz, H Druid, S Jovinge, J Frisen, Science 2009 324 98 102 10.1126/science.1164680 19342590
4. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. DA Taylor, Curr Control Trials Cardiovasc Med 2001 2 208 210 10.1186/CVM-2-5-208 11806797 (Pubitemid 33019613)
5. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. CE Dunbar, M Cottler-Fox, JA O'Shaughnessy, S Doren, C Carter, R Berenson, S Brown, RC Moen, J Greenblatt, FM Stewart, SF Leitman, WH Wilson, K Cowan, NS Young, AW Nienhuis, Blood 1995 85 3048 3057 7538814
6. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. KH Schuleri, GS Feigenbaum, M Centola, ES Weiss, JM Zimmet, J Turney, J Kellner, MM Zviman, KE Hatzistergos, B Detrick, JV Conte, I McNiece, C Steenbergen, AC Lardo, JM Hare, Eur Heart J 2009 30 2722 2732 10.1093/eurheartj/ehp265 19586959
7. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. K Schenke-Layland, KE Rhodes, E Angelis, Y Butylkova, S Heydarkhan-Hagvall, C Gekas, R Zhang, JI Goldhaber, HK Mikkola, K Plath, WR MacLellan, Stem Cells 2008 26 1537 1546 10.1634/stemcells.2008-0033 18450826
8. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. G Narazaki, H Uosaki, M Teranishi, K Okita, B Kim, S Matsuoka, S Yamanaka, JK Yamashita, Circulation 2008 118 498 506 10.1161/CIRCULATIONAHA.108.769562 18625891
9. Functional cardiomyocytes derived from human induced pluripotent stem cells. J Zhang, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson, TJ Kamp, Circ Res 2009 104 30 e41 10.1161/CIRCRESAHA.108.192237 19213953
10. Embryonic stem cell lines derived from human blastocysts. JA Thomson, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall, JM Jones, Science 1998 282 1145 1147 9804556 (Pubitemid 28516247)
11. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. K Takahashi, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda, S Yamanaka, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
12. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. M Grskovic, A Javaherian, B Strulovici, GQ Daley, Nat Rev Drug Discov 2011 10 915 929 22076509
13. Inducing translation. K Garber, Nat Biotechnol 2013 31 483 486 10.1038/nbt.2602 23752423
14. Embryonic stem cell trials for macular degeneration: a preliminary report. SD Schwartz, JP Hubschman, G Heilwell, V Franco-Cardenas, CK Pan, RM Ostrick, E Mickunas, R Gay, I Klimanskaya, R Lanza, Lancet 2012 379 713 720 10.1016/S0140-6736(12)60028-2 22281388
15. European Medicines Agency, Reflection paper on stem cell-based medicinal products 2011 http://www.ema.europa.eu/docs/en-GB/document-library/Scientific- guideline/2011/02/WC500101692.pdf
16. Good manufacturing practice and clinical-grade human embryonic stem cell lines. C Unger, H Skottman, P Blomberg, MS Dilber, O Hovatta, Hum Mol Genet 2008 17 48 R53 10.1093/hmg/ddn079 18632697
17. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. MA Laflamme, KY Chen, AV Naumova, V Muskheli, JA Fugate, SK Dupras, H Reinecke, C Xu, M Hassanipour, S Police, C O'Sullivan, L Collins, Y Chen, E Minami, EA Gill, S Ueno, C Yuan, J Gold, CE Murry, Nat Biotechnol 2007 25 1015 1024 10.1038/nbt1327 17721512 (Pubitemid 47517637)
18. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. G Blin, D Nury, S Stefanovic, T Neri, O Guillevic, B Brinon, V Bellamy, C Rucker-Martin, P Barbry, A Bel, P Bruneval, C Cowan, J Pouly, S Mitalipov, E Gouadon, P Binder, A Hagege, M Desnos, JF Renaud, P Menasche, M Puceat, J Clin Invest 2010 120 1125 1139 10.1172/JCI40120 20335662
19. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. J Nussbaum, E Minami, MA Laflamme, JA Virag, CB Ware, A Masino, V Muskheli, L Pabon, H Reinecke, CE Murry, FASEB J 2007 21 1345 1357 10.1096/fj.06-6769com 17284483 (Pubitemid 46684837)
20. Somatic coding mutations in human induced pluripotent stem cells. A Gore, Z Li, HL Fung, JE Young, S Agarwal, J Antosiewicz-Bourget, I Canto, A Giorgetti, MA Israel, E Kiskinis, JH Lee, YH Loh, PD Manos, N Montserrat, AD Panopoulos, S Ruiz, ML Wilbert, J Yu, EF Kirkness, JC Izpisua Belmonte, DJ Rossi, JA Thomson, K Eggan, GQ Daley, LS Goldstein, K Zhang, Nature 2011 471 63 67 10.1038/nature09805 21368825
21. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. R Lister, M Pelizzola, YS Kida, RD Hawkins, JR Nery, G Hon, J Antosiewicz-Bourget, R O'Malley, R Castanon, S Klugman, M Downes, R Yu, R Stewart, B Ren, JA Thomson, RM Evans, JR Ecker, Nature 2011 471 68 73 10.1038/nature09798 21289626
22. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. I Kehat, L Khimovich, O Caspi, A Gepstein, R Shofti, G Arbel, I Huber, J Satin, J Itskovitz-Eldor, L Gepstein, Nat Biotechnol 2004 22 1282 1289 10.1038/nbt1014 15448703 (Pubitemid 39341201)
23. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. C Xu, S Police, N Rao, MK Carpenter, Circ Res 2002 91 501 508 10.1161/01.RES.0000035254.80718.91 12242268
24. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. WZ Zhu, B Van Biber, MA Laflamme, Methods Mol Biol 2011 767 419 431 10.1007/978-1-61779-201-4-31 21822893
25. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. Y Ren, MY Lee, S Schliffke, J Paavola, PJ Amos, X Ge, M Ye, S Zhu, G Senyei, L Lum, BE Ehrlich, Y Qyang, J Mol Cell Cardiol 2011 51 280 287 10.1016/j.yjmcc.2011.04.012 21569778
26. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. X Lian, C Hsiao, G Wilson, K Zhu, LB Hazeltine, SM Azarin, KK Raval, J Zhang, TJ Kamp, SP Palecek, Proc Natl Acad Sci U S A 2012 109 1848 E1857 10.1073/pnas.1200250109 22645348
27. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. NC Dubois, AM Craft, P Sharma, DA Elliott, EG Stanley, AG Elefanty, A Gramolini, G Keller, Nat Biotechnol 2011 29 1011 1018 10.1038/nbt.2005 22020386
28. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. S Tohyama, F Hattori, M Sano, T Hishiki, Y Nagahata, T Matsuura, H Hashimoto, T Suzuki, H Yamashita, Y Satoh, T Egashira, T Seki, N Muraoka, H Yamakawa, Y Ohgino, T Tanaka, M Yoichi, S Yuasa, M Murata, M Suematsu, K Fukuda, Cell Stem Cell 2013 12 127 137 10.1016/j.stem.2012.09.013 23168164
29. Nongenetic method for purifying stem cell-derived cardiomyocytes. F Hattori, H Chen, H Yamashita, S Tohyama, YS Satoh, S Yuasa, W Li, H Yamakawa, T Tanaka, T Onitsuka, K Shimoji, Y Ohno, T Egashira, R Kaneda, M Murata, K Hidaka, T Morisaki, E Sasaki, T Suzuki, M Sano, S Makino, S Oikawa, K Fukuda, Nat Methods 2010 7 61 66 10.1038/nmeth.1403 19946277
30. Reconsidering pluripotency tests: do we still need teratoma assays? C Buta, R David, R Dressel, M Emgard, C Fuchs, U Gross, L Healy, J Hescheler, R Kolar, U Martin, H Mikkers, FJ Muller, RK Schneider, AE Seiler, H Spielmann, G Weitzer, Stem Cell Res 2013 11 552 562 10.1016/j.scr.2013.03.001 23611953
31. Human cardiovascular progenitor cells develop from a KDR + embryonic-stem-cell-derived population. L Yang, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, RM Linden, LJ Field, GM Keller, Nature 2008 453 524 528 10.1038/nature06894 18432194 (Pubitemid 351733312)
32. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. SD Lundy, WZ Zhu, M Regnier, MA Laflamme, Stem Cells Dev 2013 22 1991 2002 10.1089/scd.2012.0490 23461462
33. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. C Kim, J Wong, J Wen, S Wang, C Wang, S Spiering, NG Kan, S Forcales, PL Puri, TC Leone, JE Marine, H Calkins, DP Kelly, DP Judge, HS Chen, Nature 2013 494 105 110 10.1038/nature11799 23354045
34. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. LW van Laake, R Passier, J Monshouwer-Kloots, AJ Verkleij, DJ Lips, C Freund, K den Ouden, D Ward-van Oostwaard, J Korving, LG Tertoolen, CJ van Echteld, PA Doevendans, CL Mummery, Stem Cell Res 2007 1 9 24 10.1016/j.scr.2007.06.001 19383383 (Pubitemid 350251944)
35. Immunogenicity of pluripotent stem cells and their derivatives. PE de Almeida, JD Ransohoff, A Nahid, JC Wu, Circ Res 2013 112 549 561 10.1161/CIRCRESAHA.111.249243 23371903
36. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. JS Draper, C Pigott, JA Thomson, PW Andrews, J Anat 2002 200 249 258 10.1046/j.1469-7580.2002.00030.x 12033729 (Pubitemid 34467317)
37. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines. M Drukker, Semin Immunol 2008 20 123 129 10.1016/j.smim.2007.11.002 18160306
38. Characterization of the expression of MHC proteins in human embryonic stem cells. M Drukker, G Katz, A Urbach, M Schuldiner, G Markel, J Itskovitz-Eldor, B Reubinoff, O Mandelboim, N Benvenisty, Proc Natl Acad Sci U S A 2002 99 9864 9869 10.1073/pnas.142298299 12114532 (Pubitemid 34831138)
39. The immunogenicity of human embryonic stem-derived cells. M Drukker, N Benvenisty, Trends Biotechnol 2004 22 136 141 10.1016/j.tibtech.2004.01.003 15036864 (Pubitemid 38230392)
40. Histocompatible embryonic stem cells by parthenogenesis. K Kim, P Lerou, A Yabuuchi, C Lengerke, K Ng, J West, A Kirby, MJ Daly, GQ Daley, Science 2007 315 482 486 10.1126/science.1133542 17170255 (Pubitemid 46178390)
41. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. ES Revazova, NA Turovets, OD Kochetkova, LS Agapova, JL Sebastian, MV Pryzhkova, VI Smolnikova, LN Kuzmichev, JD Janus, Cloning Stem Cells 2008 10 11 24 10.1089/clo.2007.0063 18092905 (Pubitemid 351341546)
42. Immunogenicity of induced pluripotent stem cells. T Zhao, ZN Zhang, Z Rong, Y Xu, Nature 2011 474 212 215 10.1038/nature10135 21572395
43. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. M Stadtfeld, E Apostolou, H Akutsu, A Fukuda, P Follett, S Natesan, T Kono, T Shioda, K Hochedlinger, Nature 2010 465 175 181 10.1038/nature09017 20418860
44. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. P Guha, JW Morgan, G Mostoslavsky, NP Rodrigues, AS Boyd, Cell Stem Cell 2013 12 407 412 10.1016/j.stem.2013.01.006 23352605
45. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. R Araki, M Uda, Y Hoki, M Sunayama, M Nakamura, S Ando, M Sugiura, H Ideno, A Shimada, A Nifuji, M Abe, Nature 2013 494 100 104 10.1038/nature11807 23302801
46. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. F Nakajima, K Tokunaga, N Nakatsuji, Stem Cells 2007 25 983 985 10.1634/stemcells.2006-0566 17185611 (Pubitemid 46572595)
47. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. A Zimmermann, O Preynat-Seauve, JM Tiercy, KH Krause, J Villard, Stem Cells Dev 2012 21 2364 2373 10.1089/scd.2012.0088 22559254
48. Formation of human myocardium in the rat heart from human embryonic stem cells. MA Laflamme, J Gold, C Xu, M Hassanipour, E Rosler, S Police, V Muskheli, CE Murry, Am J Pathol 2005 167 663 671 10.1016/S0002-9440(10)62041-X 16127147 (Pubitemid 41216352)
49. Death and proliferation time course of stem cells transplanted in the myocardium. H Qiao, S Surti, SR Choi, K Raju, H Zhang, DE Ponde, HF Kung, J Karp, R Zhou, Mol Imaging Biol 2009 11 408 414 10.1007/s11307-009-0222-3 19459013
50. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. M Zhang, D Methot, V Poppa, Y Fujio, K Walsh, CE Murry, J Mol Cell Cardiol 2001 33 907 921 10.1006/jmcc.2001.1367 11343414 (Pubitemid 32545326)
51. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Y Shiba, S Fernandes, WZ Zhu, D Filice, V Muskheli, J Kim, NJ Palpant, J Gantz, KW Moyes, H Reinecke, B Van Biber, T Dardas, JL Mignone, A Izawa, R Hanna, M Viswanathan, JD Gold, MI Kotlikoff, N Sarvazyan, MW Kay, CE Murry, MA Laflamme, Nature 2012 489 322 325 10.1038/nature11317 22864415
52. Intramyocardial injection of pig pluripotent stem cells improves left ventricular function and perfusion: a study in a porcine model of acute myocardial infarction. X Li, F Zhang, G Song, W Gu, M Chen, B Yang, D Li, D Wang, K Cao, PLoS One 2013 8 66688 10.1371/journal.pone.0066688 23805264
53. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Q Xiong, L Ye, P Zhang, M Lepley, J Tian, J Li, L Zhang, C Swingen, JT Vaughan, DS Kaufman, J Zhang, Circulation 2013 127 997 1008 10.1161/CIRCULATIONAHA.112.000641 23371930
54. Assessment and optimization of cell engraftment after transplantation into the heart. JV Terrovitis, RR Smith, E Marban, Circ Res 2010 106 479 494 10.1161/CIRCRESAHA.109.208991 20167944
55. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. S Schaaf, A Shibamiya, M Mewe, A Eder, A Stohr, MN Hirt, T Rau, WH Zimmermann, L Conradi, T Eschenhagen, A Hansen, PLoS One 2011 6 26397 10.1371/journal.pone.0026397 22028871
56. Growth of engineered human myocardium with mechanical loading and vascular coculture. NL Tulloch, V Muskheli, MV Razumova, FS Korte, M Regnier, KD Hauch, L Pabon, H Reinecke, CE Murry, Circ Res 2011 109 47 59 10.1161/CIRCRESAHA.110.237206 21597009
57. Parthenogenetic stem cells for tissue-engineered heart repair. M Didie, P Christalla, M Rubart, V Muppala, S Doker, B Unsold, A El-Armouche, T Rau, T Eschenhagen, AP Schwoerer, H Ehmke, U Schumacher, S Fuchs, C Lange, A Becker, W Tao, JA Scherschel, MH Soonpaa, T Yang, Q Lin, M Zenke, DW Han, HR Scholer, C Rudolph, D Steinemann, B Schlegelberger, S Kattman, A Witty, G Keller, LJ Field, et al. J Clin Invest 2013 123 1285 1298 10.1172/JCI66854 23434590
58. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. A Bel, V Planat-Bernard, A Saito, L Bonnevie, V Bellamy, L Sabbah, L Bellabas, B Brinon, V Vanneaux, P Pradeau, S Peyrard, J Larghero, J Pouly, P Binder, S Garcia, T Shimizu, Y Sawa, T Okano, P Bruneval, M Desnos, AA Hagege, L Casteilla, M Puceat, P Menasche, Circulation 2010 122 118 S123 10.1161/CIRCULATIONAHA.109.927293 20837902
59. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Y Wang, WY Zhang, S Hu, F Lan, AS Lee, B Huber, L Lisowski, P Liang, M Huang, PE de Almeida, JH Won, N Sun, RC Robbins, MA Kay, FD Urnov, JC Wu, Circ Res 2012 111 1494 1503 10.1161/CIRCRESAHA.112.274969 22967807
60. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. M Campan, V Lionetti, GD Aquaro, F Forini, M Matteucci, L Vannucci, F Chiuppesi, C Di Cristofano, M Faggioni, M Maioli, L Barile, E Messina, M Lombardi, A Pucci, M Pistello, FA Recchia, Am J Physiol Heart Circ Physiol 2011 300 2238 H2250 10.1152/ajpheart.00935.2010 21335465
61. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. B Vrtovec, G Poglajen, L Lezaic, M Sever, D Domanovic, P Cernelc, A Socan, S Schrepfer, G Torre-Amione, F Haddad, JC Wu, Circ Res 2013 112 165 173 10.1161/CIRCRESAHA.112.276519 23065358
62. Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy. B Assmus, AM Zeiher, Circ Res 2013 112 6 8 10.1161/CIRCRESAHA.112.300341 23287451
63. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. J Dow, BZ Simkhovich, L Kedes, RA Kloner, Cardiovasc Res 2005 67 301 307 10.1016/j.cardiores.2005.04.011 15907822 (Pubitemid 40943623)